BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 3945454)

  • 1. Sarcomas of the uterus: a clinicopathologic study of 119 patients.
    Kahanpää KV; Wahlström T; Gröhn P; Heinonen E; Nieminen U; Widholm O
    Obstet Gynecol; 1986 Mar; 67(3):417-24. PubMed ID: 3945454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma.
    Pautier P; Genestie C; Rey A; Morice P; Roche B; Lhommé C; Haie-Meder C; Duvillard P
    Cancer; 2000 Mar; 88(6):1425-31. PubMed ID: 10717626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcome and prognostic factors in 100 cases of uterine sarcoma: experience in Helsinki University Central Hospital 1990-2001.
    Koivisto-Korander R; Butzow R; Koivisto AM; Leminen A
    Gynecol Oncol; 2008 Oct; 111(1):74-81. PubMed ID: 18657852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uterine sarcomas.
    Punnonen R; Lauslahti K; Pystynen P; Kauppila O
    Ann Chir Gynaecol Suppl; 1985; 197():11-4. PubMed ID: 3863523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Uterine sarcomas: clinical and histopathological aspects. Report on 15 cases].
    Leung F; Terzibachian JJ; Aouar Z; Govyadovskiy A; Lassabe C
    Gynecol Obstet Fertil; 2008 Jun; 36(6):628-35. PubMed ID: 18538624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A clinical analysis of 153 uterine sarcomas].
    Bai P; Sun J; Chao H
    Zhonghua Fu Chan Ke Za Zhi; 1997 Mar; 32(3):163-7. PubMed ID: 9596892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Histopathological, clinical and prognostic aspects of smooth-muscle tumors of the uterus (cellular myoma, leiomyosarcoma, endometrial stromal sarcoma)].
    De Giacomo G; Palla G; Paparatti L; Villani L; Moneta E
    Minerva Ginecol; 1988 Feb; 40(2):73-81. PubMed ID: 3399122
    [No Abstract]   [Full Text] [Related]  

  • 8. Prognostic features of sarcomas and mixed tumors of the endometrium.
    Peters WA; Kumar NB; Fleming WP; Morley GW
    Obstet Gynecol; 1984 Apr; 63(4):550-6. PubMed ID: 6322081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Purely mesenchymal homologous uterus sarcomas (leiomyosarcomas and endometrial stroma sarcomas) at the Zurich University Gynecologic Hospital].
    Bronz L; Genton CY; Kunz J; Schreiner WE
    Geburtshilfe Frauenheilkd; 1985 May; 45(5):288-93. PubMed ID: 4007466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative clinicopathologic and immunohistochemical analysis of uterine sarcomas diagnosed using the World Health Organization classification system.
    D'Angelo E; Spagnoli LG; Prat J
    Hum Pathol; 2009 Nov; 40(11):1571-85. PubMed ID: 19540555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sarcoma of the endometrium. Epidemiology and prognostic factors. Apropos of a study of 22 cases].
    Calais G; Frinot-Rousseau S; Body G; Fetissoff F; Le Floch O; Lansac J
    J Gynecol Obstet Biol Reprod (Paris); 1989; 18(7):885-9. PubMed ID: 2614028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical and pathological analysis on 106 cases with uterine sarcoma].
    Liao Q; Wang J; Han J
    Zhonghua Fu Chan Ke Za Zhi; 2001 Feb; 36(2):104-7. PubMed ID: 11783345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uterine sarcomas in Norway. A histopathological and prognostic survey of a total population from 1970 to 2000 including 419 patients.
    Abeler VM; Røyne O; Thoresen S; Danielsen HE; Nesland JM; Kristensen GB
    Histopathology; 2009 Feb; 54(3):355-64. PubMed ID: 19236512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uterine sarcomas: the Curie Institut experience. Prognosis factors and adjuvant treatments.
    Chauveinc L; Deniaud E; Plancher C; Sastre X; Amsani F; de la Rochefordiere A; Rozemberg H; Clough KB
    Gynecol Oncol; 1999 Feb; 72(2):232-7. PubMed ID: 10021306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uterine sarcoma: prognostic factors and treatment evaluation.
    Naaman Y; Shveiky D; Ben-Shachar I; Shushan A; Mejia-Gomez J; Benshushan A
    Isr Med Assoc J; 2011 Feb; 13(2):76-9. PubMed ID: 21443030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limitations of adjuvant radiotherapy for uterine sarcomas spread beyond the uterus.
    Dusenbery KE; Potish RA; Judson P
    Gynecol Oncol; 2004 Jul; 94(1):191-6. PubMed ID: 15262141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Sarcomas of the uterus: morphological criteria and clinical course (author's transl)].
    Eberl M; Pfleiderer A; Teufel G; Bachmann F
    Pathol Res Pract; 1980 Oct; 169(2):165-72. PubMed ID: 7443573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment, results and prognostic factors in stage I and II sarcomas of the corpus uteri.
    Vongtama V; Karlen JR; Piver SM; Tsukada Y; Moore RH
    AJR Am J Roentgenol; 1976 Jan; 126(1):139-47. PubMed ID: 175673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flow cytometric analysis of uterine sarcomas.
    Lennart K; Lennart B; Ulf S; Bernard T
    Gynecol Oncol; 1994 Dec; 55(3 Pt 1):339-42. PubMed ID: 7835771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Uterine sarcoma. Retrospective analysis of a series of 22 cases].
    Mage P; Chauvergne J; Bui NB; Avril A; Trojani M; Richaud P; Germain T; Maree D
    J Gynecol Obstet Biol Reprod (Paris); 1984; 13(7):802-7. PubMed ID: 6549321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.